全文获取类型
收费全文 | 63篇 |
免费 | 0篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 4篇 |
轻工业 | 7篇 |
无线电 | 8篇 |
一般工业技术 | 13篇 |
冶金工业 | 27篇 |
自动化技术 | 3篇 |
出版年
2023年 | 2篇 |
2021年 | 2篇 |
2019年 | 3篇 |
2015年 | 2篇 |
2014年 | 1篇 |
2013年 | 1篇 |
2012年 | 1篇 |
2008年 | 4篇 |
2007年 | 1篇 |
2006年 | 2篇 |
2004年 | 1篇 |
2003年 | 1篇 |
2002年 | 2篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 5篇 |
1998年 | 8篇 |
1997年 | 6篇 |
1996年 | 5篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1935年 | 1篇 |
1932年 | 2篇 |
1929年 | 1篇 |
排序方式: 共有63条查询结果,搜索用时 15 毫秒
1.
A Scalable Architecture for MPEG-4 Wavelet Quantization 总被引:3,自引:0,他引:3
Bart Vanhoof Mercedes Peón Gauthier Lafruit Jan Bormans Lode Nachtergaele Ivo Bolsens 《The Journal of VLSI Signal Processing》1999,23(1):93-107
Wavelet-based image compression has been adopted in MPEG-4 for visual texture coding. All wavelet quantization schemes in MPEG-4—Single Quantization (SQ), Multiple Quantization (MQ) and Bi-level Quantization—use Embedded Zero Tree (EZT) coding followed by an adaptive arithmetic coder for the compression and quantization of a wavelet image. This paper presents the OZONE chip, a dedicated hardware coprocessor for EZT and arithmetic coding. Realized in a 0.5 m CMOS technology and operating at 32 MHz, the EZT coder is capable of processing up to 25.6 Mega pixel-bitplanes per second. This is equivalent to the lossless compression of 31.6 8-bit grayscale CIF images (352 × 288) per second. The adaptive arithmetic coder processes up to 10 Mbit per second. The combination of the performance of the EZT coder and the arithmetic coder allows the OZONE to perform visual-lossless compression of more than 30 CIF images per second. Due to its novel and scalable architecture, parallel operation of multiple OZONEs is supported. The OZONE functionality is demonstrated on a PC-based compression system. 相似文献
2.
M Lauwereys M Arbabi Ghahroudi A Desmyter J Kinne W H?lzer E De Genst L Wyns S Muyldermans 《Canadian Metallurgical Quarterly》1998,17(13):3512-3520
Evidence is provided that dromedary heavy-chain antibodies, in vivo-matured in the absence of light chains, are a unique source of inhibitory antibodies. After immunization of a dromedary with bovine erythrocyte carbonic anhydrase and porcine pancreatic alpha-amylase, it was demonstrated that a considerable amount of heavy-chain antibodies, acting as true competitive inhibitors, circulate in the bloodstream. In contrast, the conventional antibodies apparently do not interact with the enzyme's active site. Next we illustrated that peripheral blood lymphocytes are suitable for one-step cloning of the variable domain fragments in a phage-display vector. By bio-panning, several antigen-specific single-domain fragments are readily isolated for both enzymes. In addition we show that among those isolated fragments active site binders are well represented. When produced as recombinant protein in Escherichia coli, these active site binders appear to be potent enzyme inhibitors when tested in chromogenic assays. The low complexity of the antigen-binding site of these single-domain antibodies composed of only three loops could be valuable for designing smaller synthetic inhibitors. 相似文献
3.
Erläuterung der Methoden zur Ermittlung mechanischer Spannungen unter besonderer Berücksichtigung der räumlichen Verhältnisse bei der Röntgenmessung. Darstellung der Verformungsgeometrie und der daraus abgeleiteten Meßverfahren. Vergleichende Gegenüberstellung des Röntgen-φ-Integralverfahrens mit dem Röntgen-ψ-Integralverfahren. 相似文献
4.
Forty different PCR clones encoding a llama variable heavy chain domain were analysed. The majority of these clones are derived from heavy-chain antibody cDNA in which the entire CH1 exon is absent. It appears from the amino acid within the VHH framework 1 and 3 that all the llama clones belong to the VH III family. However, the individual llama VHH sequences differ more substantially from each other than expected for members of the same family. Several remarkable amino acid substitutions in the framework 2 hinder the proper association of the VL. However, they lay the foundation for the secretion from the endoplasmic reticulum and good solubility behaviour of llama H2 antibodies. The repertoire of the llama VHHs may be extensive due to the presence of a long CDR3-loop, often constrained by a disulfide bridge and the occurrence of H1 and H2 loop conformations not yet encountered in mice or human VHs. The variability plot of the amino acids in the VHH shows that the first hypervariable region coincides with the structural H1 loop in contrast to the situation found in mice and man where the CDR1 and H1 are slightly offset. We propose that the amino acids of the llama H1 loop participate actively in the antigen binding. All these observations are characteristic for the llama VHHs of the homodimeric heavy-chain H2 antibodies, but are not maintained in the llama clones from conventional heterotetrameric H2L2 immunoglobulins. 相似文献
5.
6.
CS Dolman BM Mueller HN Lode R Xiang SD Gillies RA Reisfeld 《Canadian Metallurgical Quarterly》1998,4(10):2551-2557
Immunocytokines are antibody-cytokine fusion proteins that combine the unique targeting ability of antibodies with the multifunctional activities of cytokines to activate effector cells in the tumor microenvironment. Here, we demonstrate the therapeutic efficacy of a tumor-specific immunocytokine, huKS1/4-IL2, which effectively inhibited growth and dissemination of lung and bone marrow metastases of human prostate carcinoma in severe combined immunodeficient mice. This antitumor effect was specific and highly effective, irrespective of reconstitution of these mice with human lymphokine-activated killer cells. Survival times of mice treated with huKS1/4-IL2 were increased 4-fold as compared with animals treated with a mixture of the corresponding antibody and recombinant human interleukin-2 (rhIL2). A persistent antitumor response after treatment with the huKS1/4-IL2 immunocytokine in B, T, and natural killer cell-deficient severe combined immuodeficient-BEIGE mice, depleted of granulocytes, implies a major role for macrophages in this treatment effect. Our data demonstrate that immunocytokine-directed interleukin-2 therapy to tumor sites is an immunotherapeutic approach with potent effects against disseminated metastases of human prostate carcinoma and suggest that this treatment could be effective in an adjuvant setting for patients with minimal residual disease. 相似文献
7.
8.
HN Lode R Xiang T Dreier NM Varki SD Gillies RA Reisfeld 《Canadian Metallurgical Quarterly》1998,91(5):1706-1715
Targeted interleukin-2 (IL-2) therapy with a genetically engineered antidisialoganglioside GD2 antibody-IL-2 fusion protein induced a cell-mediated antitumor response that effectively eradicated established bone marrow and liver metastases in a syngeneic model of neuroblastoma. The mechanism involved is exclusively natural killer (NK) cell-dependent, because NK-cell deficiency abrogated the antitumor effect. In contrast, the fusion protein remained completely effective in the T-cell-deficient mice or immunocompetent mice depleted of CD8+ T cells in vivo. A strong stimulation of NK-cell activity was also shown in vitro. Immunohistology of the leukocytic infiltrate of livers from treated mice revealed a strong staining for NK cells but not for CD8+ T cells. The therapeutic effect of the fusion protein was increased when combined with NK-cell-stimulating agents, such as poly I:C or recombinant mouse interferon-gamma. In conclusion, these data show that targeted delivery of cytokines to the tumor microenvironment offers a new strategy to elicit an effective cellular immune response mediated by NK cells against metastatic neuroblastoma. This therapeutic effect may have general clinical implications for the treatment of patients with minimal residual disease who suffer from T-cell suppression after high-dose chemotherapy but are not deficient in NK cells. 相似文献
9.
HN Lode RA Reisfeld R Handgretinger KC Nicolaou G Gaedicke W Wrasidlo 《Canadian Metallurgical Quarterly》1998,58(14):2925-2928
The suppression of metastases in malignant diseases is one of the major goals in targeted chemotherapy. This was achieved with an antibody drug conjugate between a novel, rationally designed enediyene antibiotic calicheamicin theta(I)1 of exceptionally high cytotoxic potency and an antiganglioside GD2 monoclonal antibody 14G2a. Effective suppression of hepatic metastases was demonstrated in a novel syngeneic model of murine neuroblastoma that simulates the situation in patients in terms of antigen heterogeneity and presence of the target antigen on normal tissues. Here, we describe the first successful use of calicheamicin theta(I)1 for targeted chemotherapy in a clinically relevant syngeneic metastasis model. 相似文献
10.
Hagren V von Lode P Syrjälä A Korpimäki T Tuomola M Kauko O Nurmi J 《International journal of food microbiology》2008,125(2):158-161
We describe a system consisting of rapid sample enrichment and homogeneous end-point PCR analysis that enables the detection of Salmonella in various food matrices in 8 h. Sample preparation starts with 6 h enrichment step in supplemented broth, after which Salmonella cells are collected with immunomagnetic particles. The particles are washed and dispensed to ready-to-use PCR reaction vessels, which contain dried assay-specific reagents and an internal amplification control. PCR is performed with a novel instrument platform utilising the sensitive label technology of time-resolved fluorometry. Qualitative assay results are automatically interpreted and available in 45 min after sample addition. The overall accuracy, sensitivity and specificity of the Magda CA Salmonella system were 99.1%, 98.4% and 100.0%, respectively, based on the evaluation of 107 samples (beef, pork, poultry and ready-to-eat meals) artificially contaminated with sub-lethally injured Salmonella cells. 相似文献